F.D.A. Approves Remdesivir for Patients Not Hospitalized The treatment must be given via intravenous infusion over three [...] By digitalstudios|2022-01-22T16:58:04+00:00January 22, 2022|3rd Party Pharmaceutical Industry News|Comments Off on F.D.A. Approves Remdesivir for Patients Not Hospitalized Read More